Bumetanide for TSC-type Autism, Verapamil now for sinusitis, Lower dose Folinic Acid looks interesting for Autism in France, Roche cuts Balovaptan and Basmisanil; Stanford continue repurposing Vasopressin for Autism

Repurposing what already exists – cheap, safe, effective and sometimes colourful Today’s post is nice and simple. Yet another sub-type of autism is shown in a clinical trial to respond to the cheap drug bumetanide, this time it is children diagnosed with TSC ( tuberous sclerosis complex); TSC is a leading genetic cause of autism often used in research. In France researchers repurposed Folinoral, a lower dose equivalent of Dr Frye’s, and our reader Roger’s, Leucovorin to treat autism with a positive result. Folinoral is Calcium Folinate, but the dose was just 5mg twice a day, much less than the dose used in the US research. The potential off-label uses for Verapamil, the old calcium channel blocker helpful in some autism, continue to grow. Original purpose: Lower blood pressure by blocking L-type calcium channels Alternative uses: · Treating bipolar disorder · Treating cluster h...